NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT03205176 2021-05-06AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasAstraZenecaPhase 1 Completed49 enrolled